Brand drug companies impeding generic drug company access to product samples: Estimated prevalence and impact on drug costs:

Some brand drug companies have stymied attempts by generic drug companies to obtain samples of brand drugs needed to develop and gain regulatory approval for their generic products. This conduct, w...